2m 2m 2m 2m 2m 2m 2m
Protagonist Ther (PTGX)
NASDAQ
$140.18+$0.99 (+0.71%)
Price as of Oct 02, 2026 5:07 PM EDT- $9.0BMarket Cap
- 114.20%1-Year Change
- BiotechnologyIndustry
Protagonist Ther (PTGX)
$140.18+$0.99 (+0.71%)
Earnings Score
Valuation | PTGX | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 0 | ||
Growth | 1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | PTGX | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 19.51% | ||
12-Month Momentum | 128.89% | ||
3-Month Risk Adjusted Momentum | 102.09% | ||
12-Month Risk Adjusted Momentum | 260.72% |
True Yield
Valuation | PTGX | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | -0.53% | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | PTGX | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 12 |